Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Overgaard, D. Agnusdei, M. Hansen, Emmanuela Maioli, Claus Christiansen, Carlo Gennari (1991)
Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women.The Journal of clinical endocrinology and metabolism, 72 2
K. Yoh, Kiyoshi Tanaka, Aiko Ishikawa, Tomomi Ishibashi, Yuri Uchino, Yuki Sato, Mari Tobinaga, N. Hasegawa, S. Kamae, M. Yoshizawa (2004)
Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatmentJournal of Bone and Mineral Metabolism, 23
Nolten We (1976)
Treatment of senile and postmenopausal osteoporosis.Wisconsin medical journal, 75
S Gnudi, G Maggi, E Figus, E Rimondi, R Olmi, G Vellani, CA Busacchi (1986)
Efficacy of calcitonin in the symptomatic control of chronic backache due to senile osteoporosisClin Ter, 118
J. Devogelaer, M. Azria, M. Attinger, G. Abbiati, C. Castiglioni, C. Deuxchaisnes (1994)
Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogueCalcified Tissue International, 55
N. Mehta, A. Malootian, J. Gilligan (2003)
Calcitonin for osteoporosis and bone pain.Current pharmaceutical design, 9 32
VL Szejnfeld, MB Ferraz, EI Sato, E Atra (1991)
Analgesic effect of salmon calcitonin in patients with osteoporosis: randomized double blind methodRev Bras Ortop, 26
J. LeLorier, Genevieve Gregoire, Abdeltif Benhaddad, Julie Lapierre, François Derderian (1997)
Discrepancies between meta-analyses and subsequent large randomized, controlled trials.The New England journal of medicine, 337 8
M. Kopaliani (2005)
[Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].Georgian medical news, 121
D. Ofluoğlu, G. Akyuz, O. Unay, O. Kayhan (2006)
The effect of calcitonin on β-endorphin levels in postmenopausal osteoporotic patients with back painClinical Rheumatology, 26
(2005)
Interventional effects of salmon calcitonin on the bone metabolism, fracture healing and low back pain elderly patients with osteoporotic vertebral fracture
P. Peichl, B. Rintelen, W. Kumpan, H. Bröll (1999)
Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 13 1
(1991)
Vertebral body compression fractures in the elderly female. A combination of conservative arthotic treatment and calcitonin-calcium administration
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA StatementOpen Medicine, 3
P. Bordier, D. Julien, F. Caulin (1986)
Effet de la calcitonine sur la douleur osseuse et sur les paramètres de résorption secondaires à un tassement vertébral récent ― résultats d'une étude en double aveugle et d'une étude ouverteRhumatologie, 38
R. Arinoviche, M. Arriagada, S. Jacobelli, L. Massardo, S. Rivero, H. Aris, M. Valenzuela, C. Rojas, A. Carvallo, H. Gatica (1987)
[Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study].Revista medica de Chile, 115 11
B. Combe, C. Cohen, F. Aubin (1997)
Equivalence of Nasal Spray and Subcutaneous Formulations of Salmon CalcitoninCalcified Tissue International, 61
F. Christopher (1930)
Compression fractures of the spineAmerican Journal of Surgery, 9
G. Lyritis, B. Mayasis, N. Tsakalakos, A. Lambropoulos, S. Gazi, T. Karachalios, M. Tsekoura, A. Yiatzides (1989)
The natural history of the osteoporotic vertebral fractureClinical Rheumatology, 8
C. Gennari, D. Agnusdei, A. Camporeale (2007)
Use of calcitonin in the treatment of bone pain associated with osteoporosisCalcified Tissue International, 49
JD Ringe (1990)
Treatment of primary osteoporosis with calcium and salmon calcitoninDtsch Med Wochenschr, 115
G Bertolini, P Naliato, A Cruciatti, O Geatti, F Perraro (1982)
Treatment of senile and postmenopausal osteoporosis with synthetic calcitoninMed Geriatr, 14
M. Azria (2002)
Possible mechanisms of the analgesic action of calcitonin.Bone, 30 5 Suppl
M. Egger, G. Smith, Martin Schneider, C. Minder (1997)
Bias in meta-analysis detected by a simple, graphical testBMJ, 315
Jennifer Knopp, B. Diner, M. Blitz, G. Lyritis, B. Rowe (2005)
Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trialsOsteoporosis International, 16
A. Papaioannou, C. Kennedy, G. Ioannidis, A. Sawka, W. Hopman, L. Pickard, J. Brown, R. Josse, S. Kaiser, T. Anastassiades, D. Goltzman, M. Papadimitropoulos, A. Tenenhouse, J. Prior, W. Olszynski, J. Adachi, for group (2009)
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis StudyOsteoporosis International, 20
M Abellan Perez, FJ Bayina Garcia, M Calabozo, P Carpintero Benitez, M Figueroa Pedrosa, MC Fernandez Crisostomo, A Garcia Lopez, S Garcia Perez, M Mesa Ramos, J Paulino Tevar, M Rodriguez Perez, JM Salazar Vallina, A Valenzuela Castano, J Povedano Gomez, A Sanchez Trenado (1995)
Multicentric comparative study of synthetic salmon calcitonin nasally administered in the treatment of established postmenopausic osteoporosisAn Med Interna, 12
K. Jordan, Chris Cooper (1996)
THE EPIDEMIOLOGY OF OSTEOPOROSISInternational Journal of Clinical Practice, 50
M. Laroche, S. Cantogrel, B. Jamard, A. Constantin, L. Zabraniecki, A. Cantagrel, B. Mazières (2006)
Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled studyClinical Rheumatology, 25
V. Maresca (1985)
Human Calcitonin in the Management of Osteoporosis: A Multicentre StudyJournal of International Medical Research, 13
Jian Zhang (2005)
Manager Empowerment in China: Political Implications of Rural Industrialization in the Reform Era [Book Review]China Journal, 53
V. Consoli, P. Alfieri, C. Giuntini, M. Manca, F. Avaldi, R. Soncini (1991)
A double-blind placebo-controlled trial of the efficacy and tolerability of intranasal elcatonin administered to patients suffering from senile and postmenopausal osteoporosisCurrent Therapeutic Research-clinical and Experimental, 50
David Kim, A. Vaccaro (2006)
Osteoporotic compression fractures of the spine; current options and considerations for treatment.The spine journal : official journal of the North American Spine Society, 6 5
G. Lyritis, Ioannia Paspati, T. Karachalios, Dimitris Ioakimidis, G. Skarantavos, P. Lyritis (1997)
Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study.Acta orthopaedica Scandinavica. Supplementum, 275
G. Papadokostakis, J. Damilakis, E. Mantzouranis, P. Katonis, A. Hadjipavlou (2006)
The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosisEuropean Spine Journal, 15
G. Lyritis, N. Tsakalakos, B. Magiasis, T. Karachalios, A. Yiatzides, M. Tsekoura (1991)
Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical studyCalcified Tissue International, 49
M. Pascalis, D. Fletzer, A. Spirito (1983)
[Clinico-statistical study in patients with an arthrosis-osteoporosis picture in its painful stage treated with synthetic salmon calcitonin].La Clinica terapeutica, 107 3
G Attali, L Levernieux, F Caulin (1987)
Osteoporosis 1987/International Symposium on Osteoporosis
J. Higgins, D. Altman (2008)
Chapter 8: Assessing risk of bias in included studies
J. Ringe (2008)
[Treatment of primary osteoporosis with calcium and salmon calcitonin].Deutsche medizinische Wochenschrift, 115 31-32
G. Isaia, M. Stefano, A. Sciolla, M. Mussetta, D. Vassellatti (1995)
[Synthetic salmon calcitonin suppositories for the short-term treatment of involutive osteoporosis].Minerva medica, 86 3
C. Cooper, E. Atkinson, W. MichaelO'Fallon, Joseph Melton (1992)
Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989Journal of Bone and Mineral Research, 7
(1987)
Recent crush fracture syndrome. Effect of salmon calcitonin. Results of three double blind studies and one open study
M. Pérez, F. García, M. Calabozo, P. Benítez, M. Pedrosa, C. Crisóstomo, A. López, S. Pérez, M. Ramos, J. Tévar (1995)
[Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis].Anales de medicina interna, 12 1
R. Francis, T. Aspray, G. Hide, A. Sutcliffe, P. Wilkinson (2008)
Back pain in osteoporotic vertebral fracturesOsteoporosis International, 19
J. Barber, S. Gibson (2009)
Treatment of Chronic Non-Malignant Pain in the ElderlyDrug Safety, 32
T. O'Neill, W. Cockerill, C. Matthis, Heiner Raspe, Mark Lunt, C. Cooper, D. Banzer, Jimena Cannata, M. Naves, B. Felsch, D. Felsenberg, J. Janott, O. Johnell, J. Kanis, G. Kragl, A. Vaz, G. Lyritis, P. Masaryk, G. Poór, David Reid, W. Reisinger, C. Scheidt-Nave, J. Štěpán, Chris Todd, A. Woolf, J. Reeve, A. Silman (2004)
Back pain, disability, and radiographic vertebral fracture in European women: a prospective studyOsteoporosis International, 15
G. Lyritis, G. Trovas (2002)
Analgesic effects of calcitonin.Bone, 30 5 Suppl
A. Pontiroli, E. Pajetta, L. Scaglia, A. Rubinacci, G. Resmini, M. Arrigoni, G. Pozza (1994)
Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: A double-blind, double-placebo studyAging Clinical and Experimental Research, 6
D. Agnusdei, L. Condorelli, C. Gennari, H. Nakamuta, H. Rico (1996)
Intranasal Salcatonin (Salmon Calcitonin) A Review of its Pharmacological Properties and Role in the Management of Postmenopausal Osteoporosis
R. Lauro, G. Palmieri (1993)
Effect of s-calcitonin on pain related to recent osteoporotic vertebral fractures: A single-blind controlled clinical study against ipriflavone, 14
S. Gnudi, G. Maggi, E. Figus, E. Rimondi, R. Olmi, G. Vellani, Busacchi Ca (1986)
[Efficacy of calcitonin in the symptomatic control of chronic backache due to senile osteoporosis].La Clinica terapeutica, 118 2
N. Dursun, E. Dursun, Ş. Yalçin (2001)
COMPARISON OF ALENDRONATE, CALCITONIN AND CALCIUM TREATMENTS IN POSTMENOPAUSAL OSTEOPOROSISInternational Journal of Clinical Practice, 55
J. Szücs, C. Horváth, É. Kollin, M. Szathmári, I. Holló (2004)
Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spineCalcified Tissue International, 50
(1986)
Effects of a calcitonin treatment on bone pain and resorption parameters due to recent vertebral compression fracture. Results of a double blind and opened study
P. Myles, Sally Troedel, Michael Boquest, M. Reeves (1999)
The pain visual analog scale: is it linear or nonlinear?Anesthesia and analgesia, 89 6
W. Maksymowych (1998)
Managing acute osteoporotic vertebral fractures with calcitonin.Canadian family physician Medecin de famille canadien, 44
S. Cummings, L. Melton (2002)
Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 359
(1989)
Postmenopausal osteoporosis: long time therapy with calcitonin and calcium
S. Rifat, R. Kiningham, J. Peggs (1992)
Calcitonin in the treatment of osteoporotic bone pain.The Journal of family practice, 35 1
M. Nevitt, B. Ettinger, D. Black, Katie Stone, S. Jamal, K. Ensrud, M. Segal, H. Genant, S. Cummings (1998)
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective StudyAnnals of Internal Medicine, 128
C. Gennari, A. Camporeale (2010)
Calcitonin in the treatment of osteoporosisOsteoporosis International, 7
S. Gonnelli, D. Agnusdei, A. Camporeale, Rossella Palmieri, C. Gennari (1993)
Effect of rectal salmon calcitonin treatment on bone mass and bone turnover in patients with established postmenopausal osteoporosis: A 1-year crossover studyCurrent Therapeutic Research-clinical and Experimental, 54
(1988)
Treatment of senile osteoporosis with salmon calcitonin: results of a multicentric short-term study; evaluation of epidemiologic data
S. Ljunghall, P. Gärdsell, O. Johnell, K. Larsson, E. Lindh, K. Obrant, I. Sernbo (2007)
Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind studyCalcified Tissue International, 49
P Kapuscinski, M Talalaj, J Borowicz, E Marcinowska-Suchowierska, R Brzozowski (1996)
An analgesic effect of synthetic human calcitonin in patients with primary osteoporosisMater Med Pol, 28
(1986)
An evaluation of therapeutic efficiency of synthetic salmon calcitonine in osteoporosis
K. Todd, Kathleen Funk, Joseph Funk, Robert Bonacci (1996)
Clinical significance of reported changes in pain severity.Annals of emergency medicine, 27 4
JB Barber, SJ Gibson (2009)
Treatment of chronic non-malignant pain in the elderly: safety considerationsDrug Saf, 32
C. Begg, Madhuchhanda Mazumdar (1994)
Operating characteristics of a rank correlation test for publication bias.Biometrics, 50 4
J Levernieux, P Bordier, D Julien, F Caulin (1985)
5th International Congress on Calciotropic Hormones and Calcium Metabolism
G. Dilsen, D. Sindel, C. Ari (2006)
Effect of nasal calcitonin on pain in osteoporotic patients with vertebral fracturesOsteoporosis International, 6
R. Foti, U. Martorana, M. Broggini (1995)
Long-term tolerability of nasal spray formulation of salmon calcitoninCurrent Therapeutic Research-clinical and Experimental, 56
K. Pun, L. Chan (1989)
Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.Clinical therapeutics, 11 2
A Covarrubias Cobos, F Javier Escalante (1986)
Clinical experience in the treatment of osteoporosis with synthetic salmon calcitocineInvest Med Int, 13
J. Deeks, J. Higgins, D. Altman (2008)
Chapter 9: Analysing Data and Undertaking Meta-Analyses
K. Siminoski, R. Josse (1996)
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 155 7
J. Lorrain, G. Paiement, N. Chevrier, G. Lalumière, G. Laflamme, P. Caron, A. Fillion (2003)
Population demographics and socioeconomic impact of osteoporotic fractures in CanadaMenopause, 10
L Kelly Mexia, J Gonzalez Ibanez (1988)
Effectiveness of synthetic salmon calcitonin in the osteoporosis of the spineCompend Invest Clin Latinoam, 8
C. Cassis, C. Cure, S. Cassis, A. LaTorre, Jimmy Cure, Santander Crespo, O. Pérez, O. Arévalo (1985)
Uso de la calcitonina en el tratamiento multifactorial de la osteoporosis, 1
P. Kapuściński, M. Tałałaj, J. Borowicz, E. Marcinowska-Suchowierska, R. Brzozowski (2006)
Analgetic effect of synthetic human calcitonin in patients with primary osteoporosisOsteoporosis International, 6
C Holroyd, C Cooper, E Dennison (2008)
Epidemiology of osteoporosisBest Pract Res Clin Endocrinol Metab, 22
D. aloysio, F. Pansini, C. Campobasso, L. Zanotti, A. Abbruzzese, M. Mauloni, F. Bottiglioni (1996)
Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women.Clinical and experimental obstetrics & gynecology, 23 2
H. Schünemann, A. Oxman, G. Vist, Jonathan Deeks, P. Glasziou (2011)
Chapter 12: Interpreting results and drawing conclusions
(1994)
Clinical study of SMC20051 nasal spray in pain due to osteoporosis
S. Konno, S. Kikuchi (2005)
[Therapeutic effects of calcitonin on back pain in the patients with osteoporosis].Clinical calcium, 15 3
(1987)
Effect of the combined therapy in the treatment of osteoporosis: observations on the use of salmon calcitonin
MA Pascalis, DA Fletzer, A Spirito (1983)
Clinico-statistical study in patients with an arthrosis–osteoporosis picture in its painful stage treated with synthetic salmon calcitoninClin Ter, 107
R. Burge, B. Dawson-Hughes, D. Solomon, J. Wong, Alison King, A. Tosteson (2007)
Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 22
(1986)
Clinical efficacy of YM-11221 (synthetic salmon calcitonin) for back or low back pain in osteoporosis: a double blind dose finding study
A. Tolino, L. Romano, S. Ronsini, S. Riccio, U. Montemagno (1993)
Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.International journal of clinical pharmacology, therapy, and toxicology, 31 7
M. Mannarini, G. Fincato, S. Galimberti, M. Maderna, F. Greco (1994)
Analgesic effect of salmon calcitonin suppositories in patients with bone painCurrent Therapeutic Research-clinical and Experimental, 55
C. Chesnut, M. Azria, S. Silverman, M. Engelhardt, M. Olson, L. Mindeholm (2008)
Salmon calcitonin: a review of current and future therapeutic indicationsOsteoporosis International, 19
G. Lyritis, G. Ioannidis, T. Karachalios, N. Roidis, E. Kataxaki, N. Papaioannou, J. Kaloudis, A. Galanos (1999)
Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study.The Clinical journal of pain, 15 4
Vertebral collapse is a common fracture associated with osteoporosis. Subsequent pain may be severe and often requires medications and bed rest. Several studies have suggested the use of calcitonin for the treatment of fracture pain. We sought to determine the analgesic efficacy of calcitonin for acute and chronic pain of osteoporotic vertebral compression fractures (OVCF). We searched for randomized, placebo, and controlled trials that evaluated the analgesic efficacy of calcitonin for pain attributable to OVCFs. We performed meta-analyses to calculate standardized mean differences (SMDs) using a fixed or random effects model. The combined results from 13 trials (n = 589) determined that calcitonin significantly reduced the severity of acute pain in recent OVCFs. Pain at rest was reduced by week 1 [mean difference (MD) = −3.39, 95% confidence interval (CI) = −4.02 to −2.76), with continued improvement through 4 weeks. At week 4, the difference in pain scores with mobility was even greater (SMD = −5.99, 95% CI = −6.78 to −5.19). For patients with chronic pain, there was no statistical difference between groups while at rest; there was a small, statistically significant difference between groups while mobile at 6 months (SMD = 0.49, 95% CI = −0.85 to −0.13, p = 0.008). Side effects were mild, with enteric disturbances and flushing reported most frequently. Although calcitonin has proven efficacy in the management of acute back pain associated with a recent OVCF, there is no convincing evidence to support the use of calcitonin for chronic pain associated with older fractures of the same origin.
Osteoporosis International – Springer Journals
Published: Jun 10, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.